Brachytherapy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Brachytherapy Devices Market is Segmented By Technique (High Dose Rate Brachytherapy Devices and Low Dose Rate Brachytherapy Devices), By Application and Geography

Market Snapshot

Brachytherapy Devices Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %
Brachytherapy Devices Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Brachytherapy devices market is projected to register a CAGR of 5.5% during the forecast period (2021-2026)

Brachytherapy devices are commonly used for effectively treating gynecologic, prostate, breast, and other types of cancer. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and was estimated to account for 9.6 million death in 2018. Brachytherapy is related to the implementation of radioactivity within the body, to ablate or kill cancer or tumor cells within, or near the target area in the body. It is also used in combination with chemotherapy, surgery or external radiation therapy. Other factors, such as rising government initiatives to increase awareness and technological advancements in minimally invasive surgical procedures is expected to drive the brachytherapy devices market in the forecast period.

However, the lack of skilled radiologists and advanced radiotherapy facilities and reimbursement issues is among the major barrier to the growth of this market over the forecast period.

Scope of the Report

As per the scope of the report, Brachytherapy is a type of internal radiation therapy that involves the placement of radioactive material inside the patient body to treat cancer.

By Technique
High Dose Rate Brachytherapy Devices
Low Dose Rate Brachytherapy Devices
By Application
Gynecologic Cancer
Prostrate Cancer
Breast Cancer
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Breast Cancer Segment is Expected to Register a Significant Growth Over the Forecast Period

By Application, the market has been segmented into gynecologic cancer, prostate cancer, breast cancer, and others. The breast cancer segment is expected to register significant growth as compared to other cancer types. This is majorly attributed to the increasing prevalence of breast cancer across the world. As per estimates provided by the Breast Cancer Organization in 2019, an estimated 268,600 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 62,930 new cases of non-invasive (in situ) breast and this is expected to grow during the forecast period. Intracavitary brachytherapy is the most common type of brachytherapy for women with breast cancer. In this approach, a device containing radioactive substance is placed within the body and is left there until treatment is complete. In addition, rising government initiatives to increase awareness and technological advancements in minimally invasive surgical procedures also contribute to the growth of the brachytherapy devices market.

Brachytherapy Devices Market key Trends

North America Dominates the Market and Expected to do the Same Over the Forecast Period

North America dominates the market owing to the increasing incidences of cancer and early adoption of new technologies. The United States holds the majority of the market in the North American region due to high patient pool and well-developed infrastructure. However, Asia Pacific is expected to grow at a faster rate due to the increasing awareness regarding advanced treatment options, and the presence of emerging economies in this region. The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure in both urban and rural areas, that will boost the overall healthcare facility in the region.

Brachytherapy Devices Market Growth Rate

Competitive Landscape

The major players in the brachytherapy devices market includes Argon Medical Devices, Becton, Dickinson and Company, Carl Zeiss Meditec AG, Eckert & Ziegler BEBIG S.A., Elekta AB, iCAD Inc., Isoray Inc., Theragenics Corporation, and Varian Medical Systems Inc., which provides these products across the globe.

Recent Developments

In November 2020, Vivos Inc announced that it has completed its submission to the FDA seeking Breakthrough Device Designation for Radiogel. The company has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (Isopet) and in humans (Radiogel).

In August 2020, Elekta announced that its Geneva brachytherapy applicator received U.S. FDA 510(k) clearance, enabling individuals with cervical cancer in the United States to benefit from the applicator's ability to precisely target brachytherapy.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Cancer

      2. 4.2.2 Rising Government Initiatives to Increase Awareness

      3. 4.2.3 Technological Advancements in Minimally Invasive Surgical Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Radiologists and Advanced Radiotherapy Facilities

      2. 4.3.2 Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Technique

      1. 5.1.1 High Dose Rate Brachytherapy Devices

      2. 5.1.2 Low Dose Rate Brachytherapy Devices

    2. 5.2 By Application

      1. 5.2.1 Gynecologic Cancer

      2. 5.2.2 Prostrate Cancer

      3. 5.2.3 Breast Cancer

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Argon Medical Devices, Inc.

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 Eckert & Ziegler BEBIG S.A.

      5. 6.1.5 Elekta AB

      6. 6.1.6 iCAD Inc

      7. 6.1.7 Isoray Inc

      8. 6.1.8 Theragenics Corporation

      9. 6.1.9 Varian Medical Systems Inc

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Brachytherapy Devices Market market is studied from 2018 - 2026.

The Brachytherapy Devices Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Becton, Dickinson and Company, Carl Zeiss Meditec AG, Eckert & Ziegler BEBIG S.A., Elekta AB, Varian Medical Systems Inc., are the major companies operating in Brachytherapy Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!